Literature DB >> 9285909

Glucose transporters of the glomerulus and the implications for diabetic nephropathy.

C W Heilig1, F C Brosius, D N Henry.   

Abstract

Several glucose transporters have recently been identified in glomeruli, and in cultured glomerular cells. These include the facilitative glucose transporter isoforms GLUTs 1, 3 and 4, and sodium-glucose cotransport activity with characteristics of SGLT1. GLUTs 1, 3 and 4 are all high affinity, low capacity, facilitative glucose transporters which typically would be saturated at or near physiologic glucose concentrations. The SGLT transporter of mesangial cells is also a high affinity transporter which similarly could be saturated under normal glucose conditions. This suggests that in order for mesangial cells to take up excessive quantities of glucose in diabetes, changes in glucose transporter expression, translocation or activity may be required. Accordingly, recent investigations discovered positive-feedback regulation of the mesangial cell GLUT1 transporter by glucose, and a regulatory role for GLUT1 in glucose metabolism and extracellular matrix synthesis. Future investigations of glucose transporters in the pathogenesis of diabetic renal disease will now likely proceed in multiple directions, including but not limited to: (1) examination of their regulation by growth factors implicated in diabetic nephropathy, and the resultant effects on ECM synthesis; (2) determination of the mechanisms by which GLUT1 regulates the expression of aldose reductase, PKC, GLUT1, and other genes in the mesangial cell; and (3) Suppression of glucose transporters in attempts to prevent high glucose-induced diabetic glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285909

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  14 in total

1.  Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.

Authors:  C Huang; Y Kim; M L Caramori; A J Fish; S S Rich; M E Miller; G B Russell; M Mauer
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

2.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Transforming growth factor-beta1 regulation of laminin gamma1 and fibronectin expression and survival of mouse mesangial cells.

Authors:  Yan Jiang; Davis W Cheng; Errol D Crook; Lalit P Singh
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

4.  Future direction of renal positron emission tomography.

Authors:  Zsolt Szabo; Jinsong Xia; William B Mathews; Phillip R Brown
Journal:  Semin Nucl Med       Date:  2006-01       Impact factor: 4.446

Review 5.  Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

Authors:  Ravichandran Ramasamy; Ira J Goldberg
Journal:  Circ Res       Date:  2010-05-14       Impact factor: 17.367

Review 6.  The link between Glut-1 and hypertension in diabetic nephropathy.

Authors:  Luigi Gnudi; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

7.  In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy.

Authors:  E Iori; M C Marescotti; M Vedovato; G Ceolotto; A Avogaro; A Tiengo; S Del Prato; R Trevisan
Journal:  Diabetologia       Date:  2003-03-26       Impact factor: 10.122

8.  Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane.

Authors:  Joanne Marks; Nicolas J C Carvou; Edward S Debnam; Surjit K Srai; Robert J Unwin
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

9.  Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Authors:  Youli Wang; Kathleen O Heilig; Andrew W Minto; Shenglin Chen; Minghui Xiang; David A Dean; Richard C Geiger; Anthony Chang; Dimitrina D Pravtcheva; Martin Schlimme; Dilip K Deb; Ying Wang; Charles W Heilig
Journal:  Lab Invest       Date:  2009-11-16       Impact factor: 5.662

Review 10.  Ion channels and transporters in diabetic kidney disease.

Authors:  Denisha Spires; Anna D Manis; Alexander Staruschenko
Journal:  Curr Top Membr       Date:  2019-02-18       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.